ZYTIGA plus prednisone provides overall survival benefit in men with early and less aggressive mCRPC
NOTE: this press release relates to EAU 2016 Congress poster session #61, 14 March 2016. Janssen-Cilag International NV today announced that data from a post-hoc analysis of the Phase 3 COU-AA-302 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback